Rey-López et al. Respond to "The Metabolically Healthy Obesity Phenotype"

American Journal of Epidemiology

Volumn 182, Issue 9, 2015, Pages 745-746

  Rey López, Juan Pablo ^a   De Rezende, Leandro Fornias ^b   De Sá, Thiago Hérick ^b   Stamatakis, Emmanuel ^c  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BODY FAT; BODY MASS; CARDIOMETABOLIC RISK; HEALTH HAZARD; HUMAN; NOTE; OBESITY; PHENOTYPE; WEIGHT REDUCTION; HEALTH STATUS; METABOLISM; PATHOPHYSIOLOGY;

HEALTH STATUS; HUMANS; OBESITY; PHENOTYPE;

EID: 84947591858     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwv179     Document Type: Note

References (8)

1. Bradshaw PT, Stevens J. Invited commentary: limitations and usefulness of the metabolically healthy obesity phenotype. Am J Epidemiol. 2015;182(9):742-744.
2. Rey-López JP, de Rezende LF, de Sá TH, et al. Is the metabolically healthy obesity phenotype an irrelevant artifact for public health? Am J Epidemiol. 2015;182(9):737-741.
3. Gallagher D, Visser M, Sepúlveda D, et al. How useful is body mass index for comparison of body fatness across age, sex, and ethnic groups? Am J Epidemiol. 1996;143(3):228-239.
4. Rey-López JP, de Rezende LF, Pastor-Valero M, et al. The prevalence of metabolically healthy obesity: a systematic review and critical evaluation of the definitions used. Obes Rev. 2014;15(10):781-790.
5. Bray GA. Medical consequences of obesity. J Clin Endocrinol Metab. 2004;89(6):2583-2589.
6. Moodie R, Stuckler D, Monteiro C, et al. Profits and pandemics: prevention of harmful effects of tobacco, alcohol, and ultraprocessed food and drink industries. Lancet. 2013;381(9867):670-679.
7. Kleinert S, Horton R. Rethinking and reframing obesity. Lancet. 2015;385(9985):2326-2328.
8. Hill AB. The environment and disease: association or causation? Proc R Soc Med. 1965;58(5):295-300.